A cup of coffee on a desk in morning light beside a closed laptop

Caffeine can improve alertness, attention and exercise performance, but it can also disturb sleep, cause jitteriness and trigger palpitations. For healthy, non-pregnant adults, EFSA considers up to 400 mg a day, spread across the day, to raise no safety concerns, but this is not a target or a guarantee of symptom-free use.

In short

  • Count caffeine from all sources, including tea, energy drinks, supplements and some medicines.
  • EFSA’s single-dose benchmark for healthy adults is up to 200 mg, approximately 3 mg per kg body weight.
  • Even 100 mg near bedtime can affect sleep in some adults.
  • NHS pregnancy advice is no more than 200 mg a day from all sources.
  • Regular use can produce tolerance and physical dependence. Headache and fatigue after stopping are recognised withdrawal symptoms.

How caffeine affects the brain

Caffeine is a stimulant: it changes activity in the nervous system rather than supplying energy itself. One of its main actions is blocking receptors for adenosine, a chemical involved in promoting sleepiness. This helps explain both the welcome feeling of wakefulness and the unwelcome difficulty sleeping later.

The useful question is not simply whether caffeine is “healthy”. It is whether a particular amount, at a particular time, helps you without causing troublesome effects.

Caffeine also needs to be distinguished from coffee as a whole. This article concerns the stimulant; the wider drink belongs in coffee and health. Evidence about one should not automatically be treated as evidence about the other.

A hand pours black coffee into a small cup beside a larger empty cup.

Alertness and performance: useful, but specific

Attention and concentration

Controlled trials support a short-term improvement in attention. A 2025 systematic review and meta-analysis combined 31 randomised, double-blind, placebo-controlled trials involving 1,455 rested, healthy adults. Caffeine produced small average improvements in reaction time and accuracy.

That is a useful but limited finding. Performing better on an attention task is not the same as becoming more creative, making better decisions or protecting long-term brain health. The trials also tested measured doses of pure caffeine, not an unspecified mug of coffee.

For a workplace reader, the distinction matters: feeling more awake is one outcome, while doing demanding work accurately is another. The evidence supports specific short-term effects, not a general promise of better productivity.

Exercise performance

The International Society of Sports Nutrition’s evidence review finds that caffeine can improve several aspects of exercise performance, with endurance showing particularly consistent benefits. Responses vary, and some studies find no benefit.

Performance research should not be used as an invitation to take large doses. A dose studied for sport is not automatically appropriate for someone with insomnia, anxiety or a medical condition.

Under WADA’s 2026 rules, caffeine is monitored but is not prohibited. That is an anti-doping classification, not a health endorsement.

Caffeine and health: what the evidence supports

The strength descriptions below are editorial summaries, not formal clinical evidence grades. They distinguish reasonably consistent experimental findings from questions where effects vary or evidence cannot justify a broad conclusion.

Claim Type of evidence Strength and limits Source
Caffeine can improve attention briefly Meta-analysis of placebo-controlled trials Strong support for a small average short-term effect in healthy adults Kløve and colleagues, 2025
Caffeine can disrupt sleep Meta-analysis of controlled crossover trials Strong support; the size of the effect differs between studies and people Chang and colleagues, 2025
Caffeine supplements can raise blood pressure Meta-analysis of randomised trials Moderate support; supplement findings are not interchangeable with coffee findings Abbas-Hashemi and colleagues, 2023
Caffeine does not invariably increase resting heart rate Meta-analysis of longer-duration coffee and caffeine trials Limited reassurance about average resting rate, not proof that palpitations cannot occur Noordzij and colleagues, 2005
Stopping regular caffeine can cause withdrawal Review of experimental and survey studies Strong support for a recognisable, temporary withdrawal syndrome Juliano and Griffiths, 2004
Caffeine can help exercise performance Evidence review and expert position statement Good support for some activities, especially endurance; individual response varies ISSN, 2021

A meta-analysis combines results from several studies, but its conclusions still depend on the participants, doses and outcomes those studies examined. For a fuller explanation of that distinction, see how to judge the evidence.

Sleep: timing matters as well as the daily total

Sleep is a clear example of why staying below a daily benchmark does not guarantee freedom from side effects. EFSA notes that a single 100 mg dose can affect sleep duration and patterns in some adults, particularly near bedtime.

A 2025 meta-analysis of 22 controlled crossover trials, involving 956 participants, found that caffeine reduced total sleep time by about 35 minutes on average. It also reduced sleep efficiency, the proportion of time in bed actually spent asleep, and increased the time taken to fall asleep.

These are pooled averages across different study conditions, not a prediction that every coffee removes exactly that much sleep. The analysis found disruption with both lower and higher doses; it did not establish a universal cut-off time that protects everyone.

A practical response is to examine timing before assuming that your total intake is acceptable. If sleep is poor, move caffeinated drinks earlier and reduce the amount, then observe what changes. Treat this as a personal troubleshooting exercise, not a diagnostic test.

Heart rate, blood pressure and palpitations

Heart rate and blood pressure are different measurements. Caffeine can affect them differently, so “it stimulates the heart” is too vague to be useful.

A 2023 meta-analysis of randomised trials found that caffeine supplementation increased blood pressure on average. An earlier meta-analysis examining longer-duration coffee and caffeine trials found negligible average effects on heart rate, despite increases in blood pressure.

Neither result means that an individual cannot experience a racing or pounding heartbeat. The NHS lists caffeine among common triggers for palpitations, the sensation of becoming unusually aware of your heartbeat.

If palpitations keep returning, become more frequent or last longer than a few minutes, speak to a GP. Call 999 or go to A&E for ongoing palpitations that do not go away, or palpitations accompanied by chest pain, shortness of breath, feeling faint or fainting. Do not simply assume caffeine is the explanation.

Tolerance, dependence and withdrawal

Tolerance means that repeated use reduces a particular response to the same dose. It is not an all-or-nothing shield against caffeine’s effects: research on tolerance to exercise benefits is mixed, and feeling accustomed to caffeine is not a reason to keep increasing intake.

Physical dependence is different. It means that stopping or substantially reducing regular intake can produce withdrawal symptoms.

A review of experimental and survey research identified headache, fatigue, reduced alertness, difficulty concentrating and irritability among established withdrawal symptoms. Symptoms typically began 12 to 24 hours after stopping and lasted 2 to 9 days, although individual experiences varied.

This can complicate how people judge their morning coffee: relief from withdrawal may be part of the perceived benefit. It does not follow that every benefit is merely withdrawal reversal.

If you want to reduce intake, consider replacing caffeinated servings progressively rather than changing everything at once. The aim is a manageable routine, not a test of willpower. More individual troubleshooting belongs in moderation and sensitivity.

Intake guidance and sensitive groups

Healthy, non-pregnant adults

EFSA’s 2015 assessment, still presented on its current caffeine guidance page, identifies these levels as raising no safety concerns for the general healthy adult population:

  • Up to 200 mg in a single dose, approximately 3 mg per kg body weight.
  • Up to 400 mg over a day, consumed throughout the day.

These figures concern total caffeine, not coffee alone. They are population guidance, not recommended intakes, and do not establish a personal allowance for someone with symptoms or an underlying condition.

Pregnancy and breastfeeding

The NHS advises no more than 200 mg a day during pregnancy, counting all sources. It describes excessive intake as linked to a higher chance of miscarriage and stillbirth; this wording reflects an association, not proof that a particular drink caused an outcome.

Breastfeeding guidance differs between authorities. The NHS page retrieved for this article advises that cutting caffeine out is sensible and, if consuming it, trying not to exceed 300 mg a day. EFSA’s assessment identifies up to 200 mg a day as raising no safety concerns for breastfed infants.

Those are different recommendations, not interchangeable figures. Ask a midwife, health visitor, pharmacist or GP for advice suited to you and your baby, particularly if the baby seems restless.

Children, symptoms and medical conditions

The adult 400 mg benchmark is not an allowance for children. EFSA acknowledges insufficient evidence to establish a child-specific safe intake, although it proposes 3 mg per kg body weight as a basis for assessing intake of no concern.

People with anxiety, sleep problems, heart disease or high blood pressure may experience unwanted effects at lower amounts. Medicines can also matter. Ask a pharmacist or GP rather than assuming that a general adult benchmark applies to your circumstances.

Concentrated caffeine products deserve particular caution. UK guidance warns that excessive exposure can cause serious effects, including abnormal heart rhythms and seizures. Do not add supplements to a coffee routine without counting their caffeine.

Put the guidance into practice

Use this simple review of your routine:

  1. List every source. Include coffee, tea, energy drinks, chocolate, supplements and caffeine-containing medicines.
  2. Record the serving and timing. Note the actual drink size and any published caffeine information.
  3. Add the milligrams, not just the cups. NHS illustrative figures are about 100 mg for a mug of instant coffee, 140 mg for filter coffee and 75 mg for tea. Actual drinks vary.
  4. Look for unwanted effects. Note sleep difficulties, agitation, nausea or palpitations, without assuming that caffeine is necessarily their cause.
  5. Adjust or seek advice. Earlier or smaller servings may be worth trying; persistent or concerning symptoms need professional assessment.

The most useful approach to caffeine and health is to consider both the published guidance and your response. There is no reason to work upwards towards a benchmark when a smaller amount suits you.

FAQ

Does naturally occurring caffeine differ from added caffeine?

“Natural” is not a reason to exclude caffeine from your total. EFSA’s assessment covers caffeine from all dietary sources, while UK guidance specifically warns that supplements can contain substantial amounts. Count the caffeine in coffee alongside that in energy drinks, tablets and pre-workout products rather than giving one source a separate allowance.

Should I stop caffeine completely if I feel anxious?

Not necessarily, but reducing it and discussing persistent anxiety with a healthcare professional is sensible. UK guidance recognises anxiety and jitteriness as possible caffeine effects, including at lower doses in sensitive people. A change in symptoms after reducing caffeine may be useful information, but it does not diagnose the cause of anxiety.

Can cup counts tell me whether I am within the guidance?

Only approximately. NHS figures help with an initial estimate, but caffeine content and serving sizes vary. An unspecified “coffee” is therefore not a dependable unit. Use published information for the actual product where available, and do not assume that a larger drink or an extra espresso shot leaves the caffeine total unchanged.

Where to go next

Read Coffee and Health: The Evidence to understand what different study designs can establish, then Moderation and Sensitivity for a more individual approach to intake. Coffee Health Benefits and Antioxidants in Coffee cover the wider drink and its other constituents, rather than treating caffeine as the whole story.

Sources

  1. S1. European Food Safety Authority. Caffeine, current topic page summarising the 2015 assessment. Retrieved November 2026.
    https://www.efsa.europa.eu/en/topics/topic/caffeine
    Supports adult intake benchmarks, sleep effects and variation in drink content.

  2. S2. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the safety of caffeine. EFSA Journal, 2015;13(5):4102.
    https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4102
    Supports pregnancy, breastfeeding and child assessment details.

  3. S3. NHS. Foods to avoid in pregnancy. Current online guidance, retrieved November 2026.
    https://www.nhs.uk/pregnancy/keeping-well/foods-to-avoid/
    Supports pregnancy advice, sources of caffeine and pregnancy-risk wording.

  4. S4. NHS. Food and drinks to avoid when breastfeeding. Current online guidance, retrieved November 2026.
    https://www.nhs.uk/best-start-in-life/baby/feeding-your-baby/breastfeeding/healthy-diet-when-breastfeeding/food-and-drinks-to-avoid-when-breastfeeding/
    Supports the NHS breastfeeding recommendation and illustrative mug figures.

  5. S5. Food Standards Agency. Food supplements containing caffeine. Current consumer guidance, retrieved November 2026.
    https://www.gov.uk/government/publications/food-supplements-containing-caffeine
    Supports supplement awareness and lower-dose side effects in sensitive people.

  6. S6. UK government. Guidance for food business operators on food supplements containing caffeine. 2024, current online version retrieved November 2026.
    https://www.gov.uk/government/publications/guidance-for-food-operators-on-supplements-containing-caffeine/guidance-for-food-business-operators-on-food-supplements-containing-caffeine
    Supports cardiovascular cautions, excessive-intake effects and concentrated-caffeine risks.

  7. S7. NHS. Heart palpitations. Reviewed 17 March 2026.
    https://www.nhs.uk/symptoms/heart-palpitations/
    Supports symptom descriptions, caffeine as a trigger and escalation advice.

  8. S8. World Anti-Doping Agency. The 2026 Prohibited List. 2026 edition, published September 2025.
    https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
    Confirms that caffeine is monitored but not prohibited under the 2026 rules.

  9. S9. Kløve and colleagues. A systematic review and meta-analysis of the acute effect of caffeine on attention. Psychopharmacology, 2025. PubMed record.
    https://pubmed.ncbi.nlm.nih.gov/40335666/
    Supports the short-term attention findings and trial population.

  10. S10. Chang, Cheng and Cheng. Age- and dose-specific effects of caffeine on sleep: A meta-analysis of controlled crossover trials. Sleep Medicine, 2025. PubMed record.
    https://pubmed.ncbi.nlm.nih.gov/41124973/
    Supports the sleep findings, study count and participant total.

  11. S11. Abbas-Hashemi and colleagues. The effects of caffeine supplementation on blood pressure in adults: A systematic review and dose-response meta-analysis. 2023. PubMed record.
    https://pubmed.ncbi.nlm.nih.gov/38057002/
    Supports increased average blood pressure following caffeine supplementation.

  12. S12. Noordzij and colleagues. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. Journal of Hypertension, 2005. PubMed record.
    https://pubmed.ncbi.nlm.nih.gov/15834273/
    Supports the distinction between average blood-pressure and heart-rate responses.

  13. S13. Juliano and Griffiths. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology, 2004. PubMed record.
    https://pubmed.ncbi.nlm.nih.gov/15448977/
    Supports withdrawal symptoms, timing and the role of withdrawal avoidance.

  14. S14. Guest and colleagues, International Society of Sports Nutrition. International society of sports nutrition position stand: caffeine and exercise performance. Journal of the International Society of Sports Nutrition, 2021;18:1.
    https://link.springer.com/article/10.1186/s12970-020-00383-4
    Supports adenosine-receptor action, exercise effects and uncertainty about tolerance.

This article was researched using retrieved official guidance and peer-reviewed review records, distinguishing controlled effects from associations and general guidance from individual advice.

Last checked: November 2026